RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage

PLoS Biology

Volumn 12, Issue 3, 2014, Pages

  Ramdzan, Zubaidah M ^a   Vadnais, Charles ^a,b   Pal, Ranjana ^a   Vandal, Guillaume ^a,b   Cadieux, Chantal ^a,b   Leduy, Lam ^a   Davoudi, Sayeh ^a,b   Hulea, Laura ^a,b   Yao, Lu ^a,b   Karnezis, Anthony N ^c   Paquet, Marilène ^d   Dankort, David ^a,b   Nepveu, Alain ^a,b,e  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL AGING; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; GENES, RAS; HOMEODOMAIN PROTEINS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, TRANSGENIC; NUCLEAR PROTEINS; OXIDATIVE STRESS; REPRESSOR PROTEINS;

EID: 84898983512     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001807     Document Type: Article

References (106)

1. Karnoub, Weinberg, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
2. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D, (2011) RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 11: 761-774.
3. Weinberg RA, (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49: 3713-3721.
4. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
5. Campisi J, (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522.
6. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, et al. (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274: 7936-7940.
7. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, et al. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652.
8. Mitsushita J, Lambeth JD, Kamata T, (2004) The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 64: 3580-3585.
9. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, et al. (2012) ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31: 1117-1129.
10. Grollman AP, Moriya M, (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 9: 246-249.
11. Friedberg EC, Walker GC, Siede W (2006) DNA Repair and Mutagenesis. Washington, DC: ASM Press.
12. Rai P, Onder TT, Young JJ, McFaline JL, Pang B, et al. (2009) Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc Natl Acad Sci U S A 106: 169-174.
13. Rai P, Young JJ, Burton DG, Giribaldi MG, Onder TT, et al. (2011) Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene 30: 1489-1496.
14. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 98: 13784-13789.
15. Buchholz M, Braun M, Heidenblut A, Kestler HA, Kloppel G, et al. (2005) Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24: 6626-6636.
16. Luo J, Solimini NL, Elledge SJ, (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136: 823-837.
17. Sansregret L, Nepveu A, (2008) The multiple roles of CUX1: Insights from mouse models and cell-based assays. Gene 412: 84-94.
18. Hulea L, Nepveu A, (2012) CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases. Gene 497: 18-26.
19. Boultwood J, (2013) CUX1 in leukemia: dosage matters. Blood 121: 869-871.
20. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, et al. (1997) Loss Of Heterozygosity and Reduced Expression Of the Cutl1 Gene In Uterine Leiomyomas. Oncogene 14: 2355-2365.
21. Zeng WR, Watson P, Lin J, Jothy S, Lidereau R, et al. (1999) Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene. Oncogene 18: 2015-2021.
22. Pedersen-Bjergaard J, Andersen MT, Andersen MK, (2007) Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2007: 392-7.
23. Schoenmakers EF, Bunt J, Hermers L, Schepens M, Merkx G, et al. (2013) Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes, Chromosomes, Cancer 52: 11-23.
24. Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, et al. (2012) Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119: 6109-6117.
25. McNerney ME, Brown CD, Wang X, Bartom ET, Karmakar S, et al. (2013) CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood 121: 975-983.
26. Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, et al. (2011) Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood 118: 167-176.
27. Hindersin S, Niemeyer CM, Germing U, Göbel U, Kratz CP, (2007) Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7. Leuk Res 31: 1323-1324.
28. Patrikis M, Bryan E, Thomas N, Rice G, Quinn M, et al. (2003) Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas. Mol Carcinog 37: 61-64.
29. Moon NS, Rong Zeng W, Premdas P, Santaguida M, Berube G, et al. (2002) Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. Int J Cancer 100: 429-432.
30. Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, et al. (2010) Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood 115: 2882-2890.
31. Network TCGA, (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
32. Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, et al. (2005) CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7: 521-532.
33. Ripka S, Neesse A, Riedel J, Bug E, Aigner A, et al. (2010) CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut 59: 1101-1110.
34. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, et al. (2009) A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137: 835-848.
35. Aufiero B, Neufeld EJ, Orkin SH, (1994) Sequence-specific DNA binding of individual Cut repeats of the human CCAAT displacement/Cut homeodomain protein. Proc Natl Acad Sci U S A 91: 7757-7761.
36. Harada R, Dufort D, Denis-Larose C, Nepveu A, (1994) Conserved cut repeats in the human cut homeodomain protein function as DNA binding domains. J Biol Chem 269: 2062-2067.
37. Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH, (1992) Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut. Nat Genet 1: 50-55.
38. Andres V, Chiara MD, Mahdavi V, (1994) A new bipartite DNA-binding domain: cooperative interaction between the cut repeat and homeo domain of the cut homeo proteins. Genes Dev 8: 245-257.
39. Moon NS, Berube G, Nepveu A, (2000) CCAAT displacement activity involves Cut repeats 1 and 2, not the Cut homeodomain. J Biol Chem 275: 31325-31334.
40. Moon NS, Premdas P, Truscott M, Leduy L, Berube G, et al. (2001) S Phase-Specific Proteolytic Cleavage Is Required to Activate Stable DNA Binding by the CDP/Cut Homeodomain Protein. Mol Cell Biol 21: 6332-6345.
41. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, et al. (2004) A Cathepsin L Isoform that Is Devoid of a Signal Peptide Localizes to the Nucleus in S Phase and Processes the CDP/Cux Transcription Factor. Mol Cell 14: 207-219.
42. Harada R, Vadnais C, Sansregret L, Leduy L, Berube G, et al. (2008) Genome-wide location analysis and expression studies reveal a role for p110 CUX1 in the activation of DNA replication genes. Nucleic Acids Res 36: 189-202.
43. Kedinger V, Sansregret L, Harada R, Vadnais C, Cadieux C, et al. (2009) p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin. J Biol Chem 284: 27701-27711.
44. Goulet B, Watson P, Poirier M, Leduy L, Berube G, et al. (2002) Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells. Cancer Res 62: 6625-6633.
45. Sansregret L, Goulet B, Harada R, Wilson B, Leduy L, et al. (2006) The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell Biol 26: 2441-2455.
46. Truscott M, Denault JB, Goulet B, Leduy L, Salvesen GS, et al. (2007) Carboxyl-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells. J Biol Chem 282: 30216-30226.
47. Sansregret L, Vadnais C, Livingstone J, Kwiatkowski N, Awan A, et al. (2011) Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure. Proc Natl Acad Sci U S A 108: 1949-1954.
48. Vadnais C, Davoudi S, Afshin M, Harada R, Dudley R, et al. (2012) CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage. Nucleic Acids Res 40: 4483-4495.
49. Cubelos B, Sebastian-Serrano A, Beccari L, Calcagnotto ME, Cisneros E, et al. (2010) Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 66: 523-535.
50. Sinclair AM, Lee JA, Goldstein A, Xing D, Liu S, et al. (2001) Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood 98: 3658-3667.
51. Ellis T, Gambardella L, Horcher M, Tschanz S, Capol J, et al. (2001) The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle. Genes Dev 15: 2307-2319.
52. Skalnik DG, Strauss EC, Orkin SH, (1991) CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem 266: 16736-16744.
53. Lievens PMJ, Donady JJ, Tufarelli C, Neufeld EJ, (1995) Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells. J Biol Chem 270: 12745-12750.
54. Superti-Furga G, Barberis A, Schreiber E, Busslinger M, (1989) The protein CDP, but not CP1, Footprints on the CCAAT region of the g-globulin gene in unfractionated B-cell extracts. Biochim Biophys Acta 1007: 237-242.
55. Stunkel W, Huang Z, Tan SH, O'Connor MJ, Bernard HU, (2000) Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA. J Virol 74: 2489-2501.
56. Pattison S, Skalnik DG, Roman A, (1997) Ccaat Displacement Protein, a Regulator Of Differentiation-Specific Gene Expression, Binds a Negative Regulatory Element Within the 5′ End Of the Human Papillomavirus Type 6 Long Control Region. J Virol 71: 2013-2022.
57. Cadieux C, Kedinger V, Yao L, Vadnais C, Drossos M, et al. (2009) Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cancer Res 69: 7188-7197.
58. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, et al. (1996) Single-copy transgenic mice with chosen-site integration [see comments]. Proc Natl Acad Sci U S A 93: 9067-9072.
59. Maitra U, Seo J, Lozano MM, Dudley JP, (2006) Differentiation-induced cleavage of Cutl1/CDP generates a novel dominant-negative isoform that regulates mammary gene expression. Mol Cell Biol 26: 7466-7478.
60. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA, (1987) Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2: 55-59.
61. Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP, (1988) Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts. J Clin Invest 81: 1621-1629.
62. Chambers AF, Colella R, Denhardt DT, Wilson SM, (1992) Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Carcinog 5: 238-245.
63. Goulet B, Sansregret L, Leduy L, Bogyo M, Weber E, et al. (2007) Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 5: 899-907.
64. Hatahet Z, Kow YW, Purmal AA, Cunningham RP, Wallace SS, (1994) New substrates for old enzymes. 5-Hydroxy-2′-deoxycytidine and 5-hydroxy-2′-deoxyuridine are substrates for Escherichia coli endonuclease III and formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2′-deoxyuridine is a substrate for uracil DNA N-glycosylase. J Biol Chem 269: 18814-18820.
65. Steckel M, Molina-Arcas M, Weigelt B, Marani M, Warne PH, et al. (2012) Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res 22: 1227-1245.
66. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T, (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88.
67. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, et al. (1977) Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst 58: 1795-1806.
68. Truscott M, Raynal L, Premdas P, Goulet B, Leduy L, et al. (2003) CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter. Mol Cell Biol 23: 3013-3028.
69. Collado M, Serrano M, (2005) The senescent side of tumor suppression. Cell Cycle 4: 1722-1724.
70. Dankort D, Filenova E, Collado M, Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
71. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
72. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, et al. (2009) p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 11: 1135-1142.
73. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133: 1019-1031.
74. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
75. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, et al. (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10: 459-472.
76. Collado M, Serrano M, (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51-57.
77. Bennecke M, Kriegl L, Bajbouj M, Retzlaff K, Robine S, et al. (2010) Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell 18: 135-146.
78. Bihani T, Mason DX, Jackson TJ, Chen SC, Boettner B, et al. (2004) Differential oncogenic Ras signaling and senescence in tumor cells. Cell Cycle 3: 1201-1207.
79. Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Lam SH, et al. (2011) A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish. Dis Model Mech 4: 801-813.
80. Scaglioni P, Rabellino A, Yung T, Bernardi R, Choi S, et al. (2012) Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence. EMBO Mol Med 4: 594-602.
81. Vicent S, Chen R, Sayles LC, Lin C, Walker RG, et al. (2010) Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest 120: 3940-3952.
82. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. (2005) Tumour biology: senescence in premalignant tumours. Nature 436: 642.
83. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS, (2010) The essence of senescence. Genes Dev 24: 2463-2479.
84. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas, et al. (2003) Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4: 111-120.
85. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, et al. (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9: 493-505.
86. D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, et al. (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7: 235-239.
87. Potenza N, Vecchione C, Notte A, De Rienzo A, Rosica A, et al. (2005) Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep 6: 432-437.
88. Gagne JP, Pic E, Isabelle M, Krietsch J, Ethier C, et al. (2012) Quantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress. Nucleic Acids Res 40: 7788-7805.
89. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
90. Nepveu A, (2001) Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270: 1-15.
91. Harada R, Nepveu A, (2012) Chromatin affinity purification. Methods Mol Biol 809: 237-253.
92. Underhill C, Toulmonde M, Bonnefoi H, (2011) A review of PARP inhibitors: from bench to bedside. Ann Oncol 22: 268-279.
93. Shaheen M, Allen C, Nickoloff JA, Hromas R, (2011) Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood 117: 6074-6082.
94. Cadieux C, Fournier S, Peterson AC, Bedard C, Bedell BJ, et al. (2006) Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res 66: 9492-9501.
95. Cadieux C, Harada R, Paquet M, Cote O, Trudel M, et al. (2008) Polycystic kidneys caused by sustained expression of Cux1 isoform p75. J Biol Chem 283: 13817-13824.
96. Geiling B, Vandal G, Posner AR, de Bruyns A, Dutchak KL, et al. (2013) A modular lentiviral and retroviral construction system to rapidly generate vectors for gene expression and gene knockdown in vitro and in vivo. PLoS One 8: e76279.
97. Kutner RH, Zhang XY, Reiser J, (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4: 495-505.
98. DuPage M, Dooley AL, Jacks T, (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4: 1064-1072.
99. Vandal G, Geiling B, Dankort D, (2014) Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation. PLoS ONE 9: e84745.
100. Johnson LG, Vanhook MK, Coyne CB, Haykal-Coates N, Gavett SH, (2003) Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum Gene Ther 14: 729-747.
101. Olive PL, Banath JP, (2006) The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1: 23-29.
102. Collins AR, Duthie SJ, Dobson VL, (1993) Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14: 1733-1735.
103. Singh B, Bhat NK, Bhat HK, (2012) Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis 33: 156-163.
104. Huang X, Powell J, Mooney LA, Li C, Frenkel K, (2001) Importance of complete DNA digestion in minimizing variability of 8-oxo-dG analyses. Free Radic Biol Med 31: 1341-1351.
105. Hill JW, Evans MK, (2006) Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res 34: 1620-1632.
106. Paz-Elizur T, Elinger D, Leitner-Dagan Y, Blumenstein S, Krupsky M, et al. (2007) Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair 6: 45-60.